These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10219272)

  • 21. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study].
    Kozik A; Ujma-Czapska B; Grotowska M
    Neurol Neurochir Pol; 2000; 34 Suppl 1():187-93. PubMed ID: 10768158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy.
    Mattson RH; Petroff OA; Rothman D; Behar K
    Acta Neurol Scand Suppl; 1995; 162():27-30. PubMed ID: 7495186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2000 Jun; 41(6):675-80. PubMed ID: 10840398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy.
    Juhász C; Muzik O; Chugani DC; Shen C; Janisse J; Chugani HT
    Epilepsia; 2001 Oct; 42(10):1320-6. PubMed ID: 11737167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group.
    Mauguière F; Chauvel P; Dewailly J; Dousse N
    Epilepsia; 1997 Mar; 38(3):301-8. PubMed ID: 9070592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
    Spanaki MV; Siegel H; Kopylev L; Fazilat S; Dean A; Liow K; Ben-Menachem E; Gaillard WD; Theodore WH
    Neurology; 1999 Oct; 53(7):1518-22. PubMed ID: 10534261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S; Coulombe G; Carmant L
    Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vigabatrin withdrawal randomized study in children.
    Chiron C; Dulac O; Gram L
    Epilepsy Res; 1996 Nov; 25(3):209-15. PubMed ID: 8956918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study.
    Feucht M; Brantner-Inthaler S
    Epilepsia; 1994; 35(5):993-8. PubMed ID: 7925171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open label trial with vigabatrin in children with intractable epilepsy.
    Wong V
    Brain Dev; 1995; 17(4):249-52. PubMed ID: 7503385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs.
    Armijo JA; Cuadrado A; Bravo J; Arteaga R
    Ther Drug Monit; 1997 Oct; 19(5):491-8. PubMed ID: 9357089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse effects of vigabatrin in Angelman syndrome.
    Kuenzle C; Steinlin M; Wohlrab G; Boltshauser E; Schmitt B
    Epilepsia; 1998 Nov; 39(11):1213-5. PubMed ID: 9821987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vigabatrin.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 2():S95-104. PubMed ID: 8784218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigabatrin.
    Shields WD; Sankar R
    Semin Pediatr Neurol; 1997 Mar; 4(1):43-50. PubMed ID: 9097366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of brain gamma-aminobutyric acid levels is associated with vigabatrin-associated brain abnormalities on magnetic resonance imaging.
    Ikeda A; Tomiyasu M; Yamamoto A; Tsuyusaki Y; Kawai Y; Tanabe M; Tsuji M; Iai M; Aida N; Goto T
    Epilepsy Res; 2022 Mar; 181():106881. PubMed ID: 35183975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the neuropathological effects of vigabatrin and carbamazepine in patients with newly diagnosed localization-related epilepsy using MR-based cerebral T2 relaxation time measurements.
    Van Paesschen W; Duncan JS; Connelly A
    Epilepsy Res; 1998 Jan; 29(2):155-60. PubMed ID: 9477148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.
    Dodrill CB; Arnett JL; Sommerville KW; Sussman NM
    Epilepsia; 1995 Feb; 36(2):164-73. PubMed ID: 7821274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear magnetic resonance detection of increased cortical GABA in vigabatrin-treated rats in vivo.
    Preece NE; Jackson GD; Houseman JA; Duncan JS; Williams SR
    Epilepsia; 1994; 35(2):431-6. PubMed ID: 8156969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vigabatrin: 2008 update.
    Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-vinyl GABA (vigabatrin) and mood disturbances.
    Aldenkamp AP; Vermeulen J; Mulder OG; Overweg J; Van Parys JA; Beun AM; Van 't Slot B
    Epilepsia; 1994; 35(5):999-1004. PubMed ID: 7925172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.